GC Therapeutics: A New Era for Plug-and-Play Cell TherapiesCell therapies have shown remarkable effectiveness in treating a range of blood disorders and blood-related cancers, offering outsized…Sep 19Sep 19
Published inMubadalaVenturesMetsera: Pioneering the Future of Obesity TherapeuticsFor over seven years, our healthcare team has been expanding our ventures business, supporting companies that are revolutionizing…Apr 18Apr 18
Published inMubadalaVenturesShifting the Clinical Research ParadigmA discussion with Kent Thoelke, CEO of Paradigm, on our most recent investment in clinical trial transformationJan 30, 2023Jan 30, 2023
Published inMubadalaVenturesOur Investment in Pretzel Therapeutics: Creating a Powerhouse in the Mitochondria FieldAs the “powerhouse of the cell,” mitochondria play a critical role in cell viability through a multitude of functions — from energy…Sep 13, 2022Sep 13, 2022
Published inMubadalaVenturesNavigating Biotech Funding Dynamics: Shifts in Public and Private FinanceToday, we are living through what many believe is the most exciting era in the biotech industry, an era characterized by an accelerated…Jul 22, 2022Jul 22, 2022
Published inMubadalaVenturesHealthcare Has a Data Problem. Here is How We Can Fix It.Does access to seamless data matter in healthcare? To best answer this question, consider these two scenarios for patients with the same…Dec 17, 20211Dec 17, 20211
Published inMubadalaVenturesOur Investment in Neumora: A Data Sciences-Driven Precision Approach to Treating Central Nervous…Central nervous system (CNS) diseases, which include neurodegenerative disorders and neuropsychiatric illnesses, have placed a significant…Oct 7, 2021Oct 7, 2021
Published inMubadalaVenturesReimaging the Drug Value ChainHow EQRx is Improving Access to Life-Saving MedicinesAug 16, 2021Aug 16, 2021
A Conversation with Chris Gibson, Co-Founder + CEO of RecursionI sat down with Chris Gibson, Co-Founder and CEO of Recursion, off the heels of their recent IPO, to talk about his journey transforming…Jun 8, 2021Jun 8, 2021
The Future of Drug Discovery: Our Journey with Recursion PharmaWhen Mubadala Capital launched its ventures platform in San Francisco three years ago, we had a simple mission: partner early with…Sep 10, 2020Sep 10, 2020